Results 261 to 270 of about 158,362 (293)
Some of the next articles are maybe not open access.
Platelet-activating factor receptor and signal transduction
Biochemical Pharmacology, 1992T, Shimizu +4 more
openaire +2 more sources
Platelet activating factor antagonists interact with GABAA receptors.
Research communications in chemical pathology and pharmacology, 1992Platelet activating factor (PAF) is ubiquitous in mammals, and may have multiple functions in the central nervous system. Triazolobenzodiazepine compounds are active both at the GABAA receptor and as PAF antagonists. To investigate whether PAF antagonist activity is involved in the actions of triazolobenzodiazepines, we examined effects of two non ...
L G, Miller +5 more
openaire +1 more source
A novel platelet activating factor receptor antagonist
Prostaglandins, 1985C.M. Winslow +8 more
openaire +1 more source
Platelet-activating factor (PAF) receptor
Trends in Pharmacological Sciences, 2001openaire +1 more source
Platelet-activating factor receptor and signal transduction mechanisms.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1992Platelet-activating factor (PAF) is the most potent phospholipid agonist known to date. Radioligand binding studies using [3H]PAF and structurally different PAF antagonists have provided the characteristics of PAF receptor(s) and its heterogeneity. Although efforts have been made to isolate the receptor, it was not until the recent cloning of the PAF ...
openaire +1 more source
Platelet-activating factor (PAF) receptor
Trends in Pharmacological Sciences, 1997openaire +1 more source
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer
Ca-A Cancer Journal for Clinicians, 2020Grace M Choong +2 more
exaly